ASCO eLearning Podcasts
ASCO Guidelines: Use of Endocrine Therapy for Breast Cancer Risk Reduction Guideline
ASCO eLearning Podcasts
An interview with Dr. Kala Visvanathan from Sidney Kimmel Comprehensive Cancer Center, and Johns Hopkins Bloomberg School of Public Health on the guideline update. This update adds anastrozole to the options of pharmacologic interventions for breast cancer risk reduction based on recent practice changing data. Read the full guideline at www.asco.org/breast-cancer-guidelines.
Episode 2: Living Our Values
In this episode of ASCO eLearning's Social Determinants of Health (SDOH) series, Narjust Duma, MD, moderates a discussion with ASCO CEO,...
Episode 1: Beginning the Conversation – Social Determinants of Health and Cancer Care
In ASCO eLearning’s first Social Determinants of Health (SDOH) series episode, Dr. Ramy Sedhom, MD moderates a discussion with ASCO...
CAR T-cells in Pediatric ALL
Dr. Stephen Hunger is a Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. In today's ASCO...
Contrasting Cases: EGFR Mutant NSCLC
Dr. Raja Mudad is a medical oncologist specializing in lung cancer at Florida Precision Oncology. In today's ASCO eLearning Podcast, Dr....
Contrasting Cases: Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade
Dr. Doug Johnson is an Associate Professor of Medicine and Leader of Melanoma Program at the VanDr. Doug Johnson is an Associate Professor...
Contrasting Cases: Cultural Barriers to Care
Dr. Rodrigo Munhoz is a Melanoma/Sarcoma Oncologist at Hospital Sírio Libanês in São Paulo, Brazil. In today’s ASCO eLearning Podcast,...
Contrasting Cases: Systemic Therapy for Metastatic Triple-negative Breast Cancer
In this month's ASCO eLearning Podcast, Dr. Helen Chew, Professor of Medicine and leader of the Clinical Breast Cancer Program at University...
Recent Approvals: Erdafitinib and Enfortumab for Second-Line Treatment of Metastatic Bladder Cancer
Dr. Winston Tan, Medical Oncologist at Mayo Clinic, discusses the recent FDA approval of erdafitinib and enfortumab for second-line...
Management of Immune-related Adverse Events Refractory to Standard Therapies
Dr. Doug Johnson, clinical director of the melanoma program and assistant professor of medicine at Vanderbilt University Medical Center,...
ASCO Guidelines: Molecular Biomarkers in Localized Prostate Cancer Guideline
An interview with Dr. Scott Eggener of University of Chicago Medicine on "Molecular Biomarkers in Localized Prostate Cancer: ASCO...
ASCO Guidelines: Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards
An interview with Dr. Melissa Dillmon on the Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards. The...
ASCO Guidelines: Disease Management for Patients With Advanced HER2 Positive Breast Cancer and Brain Metastases Guideline
An interview with Dr. Naren Ramakrishna from University of Florida Health Cancer Center at Orlando Health on the guideline update which...
ASCO Guidelines: Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Guideline
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use...
ASCO Guidelines: Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression Guideline
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use...
ASCO Guidelines: Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use...
ASCO Guidelines: Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer Update
An interview with Dr. Lynn Henry from University of Utah Huntsman Cancer Institute on "Role of Patient and Disease Factors in Adjuvant...
ASCO Voices 2019: I Promised
I Promised presented by Ashley Sumrall, MD, FACP at ASCO Annual Meeting 2019
ASCO Guidelines: Medication-Related Osteonecrosis of the Jaw Guideline
An interview with Dr. Noam Yarom, Dr. Charles Shapiro, Dr. Deborah Saunders and Dr. Doug Peterson on "Medication-Related Osteonecrosis of...
ASCO Voices 2019: Whose Breast Is It Anyway? Breast Cancer and Sexuality in Sub-Saharan Africa
ASCO Guidelines: Management of Osteoporosis in Survivors of Adult Cancers with Nonmetastatic Disease Guideline
An interview with Dr. Charles Shapiro from Mount Sinai Hospital in New York and Dr. Joan Neuner from Medical College of Wisconsin, co-chairs...
ASCO Guidelines: Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer Guideline Update
An interview with Dr. Anna Falanga on "Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Clinical Practice...
ASCO Voices 2019: The Obligation of the Cured
ASCO Voices talk by Scott Capozza, MS, PT from ASCO Annual Meeting 2019.
An interview with Dr. Kala Visvanathan from Sidney Kimmel Comprehensive Cancer Center, and Johns Hopkins Bloomberg School of Public Health...
ASCO Voices 2019: Doing Everything
Ishwaria Subbiah, MD MS
Recent Approvals: Trastuzumab and Hyaluronidase-oysk
Episode 2: Living Our Values
ASCO eLearning Podcasts
Episode 1: Beginning the Conversation – Social Determinants of Health and Cancer Care
ASCO eLearning Podcasts
CAR T-cells in Pediatric ALL
ASCO eLearning Podcasts
